INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical ...
NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new ...
Zydus Lifesciences on Saturday announced the launch of Semaglutide Injection in India under the brand names SEMAGLYN™, MASHEMA™ and ALTERME™, following patent expiry.
The core needle biopsy (CNB) procedure is an essential part of breast cancer diagnosis. Current CNB devices on the market are not suitable for low-resource settings, which makes early breast cancer ...
NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering a ...
PharmaJet, a commercial-stage world leader in needle-free injection systems to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announced that it ...
Zydus Lifesciences Limited has launched Semaglutide Injection in India under the brand names SEMAGLYN, MASHEMA, and ALTERME ...
(MENAFN- IMARC Group) Insulin pens are convenient, pre-filled or reusable injection devices designed for people with diabetes to administer insulin. They typically consist of an insulin cartridge, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results